Publications

2018

82.
Srivastava G., Moseri A., Kessler N., Arshava B., Naider F. & Anglister J. (2018) FEBS Journal. 285, 22, p. 4296-4310  Abstract
81.
Abayev M., Rodrigues J. P. G. L. M., Srivastava G., Arshava B., Jaremko L., Jaremko M., Naider F., Levitt M. & Anglister J. (2018) FEBS Journal. 285, 11, p. 1988-2003  Abstract
80.
Naider F. & Anglister J. (2018) Protein and Peptide Letters. 25, 12, p. 1124-1136  Abstract

2017

79.
Abayev M., Srivastava G., Arshava B., Naider F. & Anglister J. (2017) FEBS Journal. 284, 4, p. 586-601  Abstract
78.
Moseri A., Sinha E., Zommer H., Arshava B., Naider F. & Anglister J. (2017) Vaccine. 35, 2, p. 222-230  Abstract

2016

77.
Srivastava G., Moseri A., Kessler N., Akabayov S. R., Arshava B., Naider F. & Anglister J. (2016) FEBS Journal. 283, 22, p. 4084-4096  Abstract
76.
Anglister J., Srivastava G. & Naider F. (2016) Progress in Nuclear Magnetic Resonance Spectroscopy. 97, p. 40-56  Abstract

2015

75.
Moseri A., Biron Z., Arshava B., Scherf T., Naider F. & Anglister J. (2015) The FEBS journal. 282, 24, p. 4643-57  Abstract
74.
Abayev M., Moseri A., Tchaicheeyan O., Kessler N., Arshava B., Naider F., Scherf T. & Anglister J. (2015) FEBS Journal. 282, 10, p. 1906-1921  Abstract

2014

73.
Moseri A., Schnur E., Noah E. et al. (2014) FEBS Journal. 281, 13, p. 3019-3031  Abstract [All authors]

2013

72.
Schnur E., Kessler N., Zherdev Y. et al. (2013) FEBS Journal. 280, 9, p. 2068-2084  Abstract [All authors]
71.
Moseri A., Tantry S., Ding F., Naider F. & Anglister J. (2013) AIDS Research and Human Retroviruses. 29, 4, p. 718-724  Abstract

2011

70.
Nudelman I., Akabayov S. R., Scherf T. & Anglister J. (2011) Journal of the American Chemical Society. 133, 37, p. 14755-14764  Abstract
69.
Schnur E., Noah E., Ayzenshtat I. et al. (2011) Journal of Molecular Biology. 410, 5, p. 778-797  Abstract [All authors]

2010

68.
Nudelman I., Akabayov S. R., Schnur E., Biron Z., Levy R., Xu Y., Yang D. & Anglister J. (2010) Biochemistry. 49, 25, p. 5117-5133  Abstract
67.
Moseri A., Tantry S., Sagi Y., Arshava B., Naider F. & Anglister J. (2010) Virology. 401, 2, p. 293-304  Abstract
66.
Akabayov S. R., Biron Z., Lamken P., Piehler J. & Anglister J. (2010) Biochemistry. 49, 4, p. 687-695  Abstract

2009

65.
Mester B., Manor R., Mor A., Arshava B., Rosen O., Ding F., Naider F. & Anglister J. (2009) Biochemistry. 48, 33, p. 7867-7877  Abstract
64.
Naider F. & Anglister J. (2009) Current Opinion in Structural Biology. 19, 4, p. 473-482  Abstract
63.
Mor A., Segal E., Mester B. et al. (2009) Biochemistry. 48, 15, p. 3288-3303  Abstract [All authors]
62.
Rosen O. & Anglister J. (2009) Epitope Mapping Protocols. Second Edition ed. p. 37-57 (Methods in Molecular Biology).  Abstract

2008

61.
Noah E., Biron Z., Naider F., Arshava B. & Anglister J. (2008) Biochemistry. 47, 26, p. 6782-6792  Abstract
60.
Rosen O., Samson A. O. & Anglister J. (2008) Proteins-Structure Function And Bioinformatics. 71, 3, p. 1066-1070  Abstract
59.
Schnur E., Turkov M., Kahn R., Gordon D., Gurevitz M. & Anglister J. (2008) Biochemistry. 47, 3, p. 911-921  Abstract

2007

58.
Anglister J., Rosen O., Sharon M., Tugarinov V., Kessler N. & Levy R. (2007) Journal of biomolecular structure & dynamics. 24, 6, p. 670-670  Abstract

2006

57.
Quadt-Akabayov S. R., Chill J. H., Levy R., Kessler N. & Anglister J. (2006) Protein Science. 15, 11, p. 2656-2668  Abstract
56.
Rosen O., Sharon M., Quadt-Akabayov S. R. & Anglister J. (2006) Proceedings of the National Academy of Sciences of the United States of America. 103, 38, p. 13950-13955  Abstract
54.
Garcia J., Dumy P., Rosen O. & Anglister J. (2006) Biochemistry. 45, 13, p. 4284-4294  Abstract

2005

53.
Biron Z., Khare S., Quadt S., Hayek Y., Naider F. & Anglister J. (2005) Biochemistry. 44, 41, p. 13602-13611  Abstract
52.
NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity
Sharon M., Rosen O. & Anglister J. (2005) Current Opinion In Drug Discovery & Development. 8, 5, p. 601-612 16159022.  Abstract
51.
Samson A., Chill J. & Anglister J. (2005) Biochemistry. 44, 32, p. 10926-10934  Abstract
50.
Rosen O., Chill J., Sharon M., Kessler N., Mester B., Zolla-Pazner S. & Anglister J. (2005) Biochemistry. 44, 19, p. 7250-7258  Abstract

2004

49.
Chill J., Quadt S. & Anglister J. (2004) Biochemistry. 43, 31, p. 10127-10137  Abstract

2003

48.
Chill J., Quadt S., Levy R., Schreiber G. & Anglister J. (2003) Structure. 11, 7, p. 791-802  Abstract
47.
Kessler N., Zvi A., Ji M., Sharon M., Rosen O., Levy R., Gorny M., Zolla-Pazner S. & Anglister J. (2003) Protein Expression and Purification. 29, 2, p. 291-303  Abstract
46.
Sharon M., Kessler N., Levy R., Zolla-Pazner S., Gorlach M. & Anglister J. (2003) Structure. 11, 2, p. 225-236  Abstract

2002

45.
Biron Z., Khare S., Samson A., Hayek Y., Naider F. & Anglister J. (2002) Biochemistry. 41, 42, p. 12687-12696  Abstract
44.
Samson A., Scherf T., Eisenstein M., Chill J. & Anglister J. (2002) Neuron. 35, 2, p. 319-332  Abstract
43.
Sharon M., Gorlach M., Levy R., Hayek Y. & Anglister J. (2002) Protein Expression and Purification. 24, 3, p. 374-383  Abstract
42.
Yao Y., Wang J., Viroonchatapan N., Samson A., Chill J., Rothe E., Anglister J. & Wang Z. (2002) Journal of Biological Chemistry. 277, 15, p. 12613-12621  Abstract
41.
Chill J., Nivasch R., Levy R., Albeck S., Schreiber G. & Anglister J. (2002) Biochemistry. 41, 11, p. 3575-3585  Abstract

2001

40.
Samson A., Chill J., Rodriguez E., Scherf T. & Anglister J. (2001) Biochemistry. 40, 18, p. 5464-5473  Abstract

2000

39.
Froy O., Zilberberg N., Chejanovsky N., Anglister J., Loret E., Shaanan B., Gordon D. & Gurevitz M. (2000) Pest Management Science. 56, 5, p. 472-474  Abstract
38.
Balbach J., Yang J., Weliky D., Steinbach P., Tugarinov V., Anglister J. & Tycko R. (2000) Journal of Biomolecular NMR. 16, 4, p. 313-327  Abstract
37.
Tugarinov V., Zvi A., Levy R., Hayek Y., Matsushita S. & Anglister J. (2000) Structure with Folding & design. 8, 4, p. 385-395  Abstract
36.
Zvi A., Tugarinov V., Faiman G., Horovitz A. & Anglister J. (2000) FEBS Journal. 267, 3, p. 767-779  Abstract
35.
Solution structure of an antibody-bound HIV-1(IIIB)V3 peptide: A cis proline turn linking two beta-hairpin strands
Tugarinov V. & Anglister J. (2000) Journal of biomolecular structure & dynamics. p. 57-63  Abstract

1999

34.
Sharon M., Oren Z., Shai Y. & Anglister J. (1999) Biochemistry. 38, 46, p. 15305-15316  Abstract
33.
A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1(IIIB) V3 peptide
Tugarinov V., Zvi A., Levy R. & Anglister J. (1999) Nature Structural Biology. 6, 4, p. 331-335  Abstract
32.
Tugarinov V., Levy R., Dahan-Schokoroy A. & Anglister J. (1999) Journal of Biomolecular NMR. 13, 2, p. 193-194  Abstract
31.
Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120
Weliky D., Bennett A., Zvi A., Anglister J., Steinbach P. & Tycko R. (1999) Nature Structural Biology. 6, 2, p. 141-145  Abstract
30.
Application of NMR to conformational studies of an HIV peptide bound to a neutralizing antibody
Zvi A. & Anglister J. (1999) Nmr In Supramolecular Chemistry. 526, p. 117-132  Abstract

1998

29.
The principal neutralizing determinant of HIV-1(IIIB): Conformation Of the peptide bound to a neutralizing antibody studied by 2D-NMR
Zvi A. & Anglister J. (1998) International Journal of Peptide Research and Therapeutics. 5, 6-May, p. 357-364  Abstract

1997

28.
Zvi A., Feigelson D., Hayek Y. & Anglister J. (1997) Biochemistry. 36, 28, p. 8619-8627  Abstract
27.
Scherf T., Balass M., Fuchs S., KatchalskiKatzir E. & Anglister J. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 12, p. 6059-6064  Abstract
26.
Tugarinov V., Kustanovich I., Zilberberg N., Gurevitz M. & Anglister J. (1997) Biochemistry. 36, 9, p. 2414-2424  Abstract

1996

25.
Contribution of arginine residues in the RP135 peptide derived from the V3 loop of gp120 to its interaction with the Fv fragment of the 0.5 beta HIV-1 neutralizing antibody
Faiman G., Levy R., Anglister J. & Horovitz A. (1996) Journal of Biological Chemistry. 271, 23, p. 13829-13833  Abstract

1995

24.
Anglister J., REN H., KLEE C. & BAX A. (1995) FEBS Letters. 375, 2-Jan, p. 108-112  Abstract
23.
ZVI A., KUSTANOVICH I., HAYEK Y., MATSUSHITA S. & Anglister J. (1995) FEBS Letters. 368, 2, p. 267-270  Abstract
22.
STRUCTURAL DIVERSITY IN A CONSERVED CHOLERA-TOXIN EPITOPE INVOLVED IN GANGLIOSIDE BINDING
Shoham M., Scherf T., Anglister J., LEVITT M., MERRITT E. & HOL W. (1995) Protein Science. 4, 5, p. 841-848  Abstract
21.
ZVI A., KUSTANOVICH I., FEIGELSON D., Levy R., Eisenstein M., MATSUSHITA S., RICHALETSECORDEL P., REGENMORTEL M. & Anglister J. (1995) FEBS Journal. 229, 1, p. 178-187  Abstract
20.
Anglister J., Scherf T., ZILBER B. & Levy R. (1995) Biopolymers. 37, 6, p. 383-389  Abstract
19.
NMR OBSERVATION OF INTERACTIONS IN THE COMBINING SITE REGION OF AN ANTIBODY USING A SPIN-LABELED PEPTIDE ANTIGEN AND NOESY DIFFERENCE SPECTROSCOPY
Scherf T., HILLER R. & Anglister J. (1995) FASEB Journal. 9, 1, p. 120-126  Abstract

1994

18.
Anglister J., GRZESIEK S., WANG A., REN H., KLEE C. & BAX A. (1994) Biochemistry. 33, 12, p. 3540-3547  Abstract

1993

17.
2-DIMENSIONAL NMR INVESTIGATIONS OF THE INTERACTIONS OF ANTIBODIES WITH PEPTIDE ANTIGENS
Anglister J., Scherf T., ZILBER B., Levy R., ZVI A., HILLER R. & FEIGELSON D. (1993) FASEB Journal. 7, 12, p. 1154-1162  Abstract
16.
A T(1-RHO)-FILTERED 2-DIMENSIONAL TRANSFERRED NOE SPECTRUM FOR STUDYING ANTIBODY INTERACTIONS WITH PEPTIDE ANTIGENS
Scherf T. & Anglister J. (1993) Biophysical Journal. 64, 3, p. 754-761  Abstract

1992

15.
ZVI A., HILLER R. & Anglister J. (1992) Biochemistry. 31, 30, p. 6972-6979  Abstract
14.
Scherf T., HILLER R., Naider F., LEVITT M. & Anglister J. (1992) Biochemistry. 31, 30, p. 6884-6897  Abstract

1991

13.
Anglister J. & Naider F. (1991) Molecular Design and Modeling: Concepts and Applications. Vol. 203. p. 228-241  Abstract

1990

12.
ZILBER B., Scherf T., LEVITT M. & Anglister J. (1990) Biochemistry. 29, 43, p. 10032-10041  Abstract
11.
USE OF DEUTERIUM LABELING IN NMR-STUDIES OF ANTIBODY COMBINING SITE STRUCTURE
Anglister J. (1990) Quarterly Reviews of Biophysics. 23, 2, p. 175-203  Abstract

1989

1988

7.
FREY T., Anglister J. & MCCONNELL H. (1988) Biochemistry. 27, 14, p. 5161-5165  Abstract
6.
Anglister J., JACOB C., ASSULIN O., AST G., PINKER R. & Arnon R. (1988) Biochemistry. 27, 2, p. 717-724  Abstract

1987

5.
Anglister J., BOND M., FREY T., LEAHY D., LEVITT M., MCCONNELL H., RULE G., TOMASELLO J. & WHITTAKER M. (1987) Biochemistry. 26, 19, p. 6058-6064  Abstract

1983

3.
Anglister J. & STEINBERG I. (1983) Journal of Chemical Physics. 78, 9, p. 5358-5368  Abstract

1981

2.
Anglister J. & STEINBERG I. (1981) Journal of Chemical Physics. 74, 2, p. 786-791  Abstract

1979

1.
Anglister J. & STEINBERG I. (1979) Chemical Physics Letters. 65, 1, p. 50-54  Abstract